Literature DB >> 23419525

Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth.

Mark Katakowski1, Ben Buller, Xuguang Zheng, Yong Lu, Thomas Rogers, Oyinkansola Osobamiro, Wayne Shu, Feng Jiang, Michael Chopp.   

Abstract

Exosomes are 30-150 nm vesicles secreted by a wide range of mammalian cells that can contain microRNA (miRNA). To test if marrow stromal cell (MSC) exosomes could be used as a vehicle for delivery of anti-tumor miRNAs, we transfected MSCs with a miR-146b expression plasmid, and harvested exosomes released by the MSCs. Intra-tumor injection of exosomes derived from miR-146-expressing MSCs significantly reduced glioma xenograft growth in a rat model of primary brain tumor.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23419525      PMCID: PMC3665755          DOI: 10.1016/j.canlet.2013.02.019

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  24 in total

Review 1.  Studying a complex tumor: potential and pitfalls.

Authors:  Siyuan Zheng; Milan G Chheda; Roel G W Verhaak
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

2.  MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma.

Authors:  Mark Katakowski; Xuguang Zheng; Feng Jiang; Thomas Rogers; Alexandra Szalad; Michael Chopp
Journal:  Cancer Invest       Date:  2010-09-27       Impact factor: 2.176

3.  Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells.

Authors:  D Bhaumik; G K Scott; S Schokrpur; C K Patil; J Campisi; C C Benz
Journal:  Oncogene       Date:  2008-05-26       Impact factor: 9.867

4.  Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma.

Authors:  Robert O Dillman; Christopher M Duma; Patric M Schiltz; Carol DePriest; Robin A Ellis; Kris Okamoto; Linda D Beutel; Cristina De Leon; Sherri Chico
Journal:  J Immunother       Date:  2004 Sep-Oct       Impact factor: 4.456

Review 5.  Causes and consequences of microRNA dysregulation in cancer.

Authors:  Carlo M Croce
Journal:  Nat Rev Genet       Date:  2009-10       Impact factor: 53.242

Review 6.  Epigenetic changes in gliomas.

Authors:  Rebecca Burgess; Robert Jenkins; Zhiguo Zhang
Journal:  Cancer Biol Ther       Date:  2008-09-18       Impact factor: 4.742

7.  Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion.

Authors:  Anita Lal; Chad A Glazer; Holly M Martinson; Henry S Friedman; Gary E Archer; John H Sampson; Gregory J Riggins
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

8.  Reduced expression of SMAD4 in gliomas correlates with progression and survival of patients.

Authors:  Shi-ming He; Zhen-wei Zhao; Yuan Wang; Ji-pei Zhao; Liang Wang; Fang Hou; Guo-dong Gao
Journal:  J Exp Clin Cancer Res       Date:  2011-07-27

9.  PDGF induced microRNA alterations in cancer cells.

Authors:  Minghai Shao; Simona Rossi; Bhadrani Chelladurai; Masayoshi Shimizu; Obiageli Ntukogu; Mircea Ivan; George A Calin; Daniela Matei
Journal:  Nucleic Acids Res       Date:  2011-01-25       Impact factor: 16.971

10.  Exosomal miRNAs: Biological Properties and Therapeutic Potential.

Authors:  Guoku Hu; Kristen M Drescher; Xian-Ming Chen
Journal:  Front Genet       Date:  2012-04-20       Impact factor: 4.599

View more
  266 in total

1.  Evaluation of electroporation-induced adverse effects on adipose-derived stem cell exosomes.

Authors:  Kasper Bendix Johnsen; Johann Mar Gudbergsson; Martin Najbjerg Skov; Gunna Christiansen; Leonid Gurevich; Torben Moos; Meg Duroux
Journal:  Cytotechnology       Date:  2016-02-08       Impact factor: 2.058

Review 2.  Synthetic nucleic acids delivered by exosomes: a potential therapeutic for generelated metabolic brain diseases.

Authors:  Rutao Liu; Jing Liu; Xiaofei Ji; Yang Liu
Journal:  Metab Brain Dis       Date:  2013-12       Impact factor: 3.584

Review 3.  Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities.

Authors:  Ali Hassanzadeh; Heshu Sulaiman Rahman; Alexander Markov; Judi Januadi Endjun; Angelina Olegovna Zekiy; Max Stanley Chartrand; Nasrin Beheshtkhoo; Mohammad Amin Jadidi Kouhbanani; Faroogh Marofi; Marzieh Nikoo; Mostafa Jarahian
Journal:  Stem Cell Res Ther       Date:  2021-05-21       Impact factor: 6.832

Review 4.  Engineering exosomes: a new direction for anticancer treatment.

Authors:  Benshuai You; Wenrong Xu; Bin Zhang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

5.  Delivery of Exogenous miR-124 to Glioblastoma Multiform Cells by Wharton's Jelly Mesenchymal Stem Cells Decreases Cell Proliferation and Migration, and Confers Chemosensitivity.

Authors:  S Sharif; M H Ghahremani; M Soleimani
Journal:  Stem Cell Rev Rep       Date:  2018-04       Impact factor: 5.739

Review 6.  RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.

Authors:  Eunice L Lozada-Delgado; Nilmary Grafals-Ruiz; Pablo E Vivas-Mejía
Journal:  Life Sci       Date:  2017-08-31       Impact factor: 5.037

7.  MicroRNA expression signatures and their correlation with clinicopathological features in glioblastoma multiforme.

Authors:  Michael Henriksen; Kasper Bendix Johnsen; Pia Olesen; Linda Pilgaard; Meg Duroux
Journal:  Neuromolecular Med       Date:  2014-05-10       Impact factor: 3.843

8.  The Potentials and Pitfalls of Using Adult Stem Cells in Cancer Treatment.

Authors:  Mrinal K Das; Taral R Lunavat; Hrvoje Miletic; Jubayer A Hossain
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  Update on current and potential nanoparticle cancer therapies.

Authors:  Jonathan S Rink; Michael P Plebanek; Sushant Tripathy; C Shad Thaxton
Journal:  Curr Opin Oncol       Date:  2013-11       Impact factor: 3.645

Review 10.  Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.

Authors:  Xiaohuan Xia; Yi Wang; Yunlong Huang; Han Zhang; Hongfang Lu; Jialin C Zheng
Journal:  Prog Neurobiol       Date:  2019-09-19       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.